Key result
Opioid-free anaesthesia lacks a universal definition, and peri-operative care should instead focus on maximizing non-opioid multi-modal analgesia while reserving opioids for severe acute pain.
Why the study?
Does opioid-free anaesthesia improve postoperative pain and reduce PONV compared to opioid-inclusive anaesthesia in surgical patients?
Does opioid-free anaesthesia improve postoperative pain and reduce PONV compared to opioid-inclusive anaesthesia in surgical patients?
Answers are grounded in this paper and cite their sources.
This editorial highlights that opioid-free anaesthesia should be defined as a comprehensive peri-operative strategy maximizing multi-modal analgesia rather than simply avoiding opioids intra-operatively.
Opioids have been used for the treatment of pain since 3400 BC by the Mesopotamians and they remain an important class of analgesic medications. More recently, attention has focused on the overprescribing of opioids and how much it has contributed to the current opioid crisis in North America 1, 2. As anaesthetists, we are in a unique position to take a leadership role in addressing the opioid epidemic 3. Patients under our care who undergo surgery, even minor outpatient procedures, are at increased risk of chronic opioid use 4. Opioids have been associated with a host of adverse effects such as nausea and vomiting, constipation, cognitive dysfunction and even sleep disturbance 5, 6. As advocates for patient safety, anaesthetists have begun to develop protocols centred on minimising or even avoiding opioids for their patients altogether. Although this concept of opioid-free anaesthesia is not yet standard practice, there is evidence to suggest that this nascent movement will continue to grow. In the past two years, there have been 20 English language articles published including the text words ‘opioid-free anesthesia’ or ‘opioid-free anaesthesia’ based on our recent search of PubMed, and this subject has been included as a lecture or session topic during the annual congresses of the European Society of Regional Anaesthesia and Pain Therapy and American Society of Regional Anesthesia and Pain Medicine. There are 10 studies listed on ClinicalTrials.gov involving opioid-free anaesthesia and currently recruiting participants. In this issue of Anaesthesia, Frauenknecht et al. present a systematic review and meta-analysis of randomised clinical trials (RCT) comparing opioid-inclusive with opioid-free anaesthetic regimens in terms of immediate postoperative pain and postoperative nausea and vomiting (PONV) 7. We applaud this group of investigators for their interest in this important and timely topic. Based on data analysed from 23 RCTs, they concluded that use of intra-operative opioids did not decrease postoperative rest pain at 2 h and was associated with an increased incidence of PONV compared with opioid-free anaesthesia. Although these positive results achieved statistical significance and potentially add support for opioid-free anaesthesia, the magnitude of benefits is limited and not completely unexpected. There are details of the meta-analysis that deserve further exploration; thus, these conclusions cannot be taken at face value and applied directly to clinical practice. We must remember that even well-conducted meta-analyses, although useful tools in generating hypotheses and evaluating evidence across a heterogeneous population 8, do not generate new data and do not provide a final answer. In this editorial, we explore additional key points that anaesthetists should carefully consider when interpreting the findings of Frauenknecht et al. 7 and determining the role of opioid-free anaesthesia in their practice. First and most importantly, we currently lack a universal definition of opioid-free anaesthesia. In the cult classic The Princess Bride, the character Inigo Montoya is quoted as saying, ‘You keep using that word. I do not think it means what you think it means.’ While Mr. Montoya is referring to the character Vizzini's repeated use of the term ‘inconceivable’ in the movie, his message applies perfectly to the general use of ‘opioid-free anaesthesia.’ In the present study, the intervention evaluated by the meta-analysis was the use of intra-operative opioids with the control being no opioids 7. Does the latter constitute opioid-free anaesthesia? Although this may seem obvious, we think it is essential to state that opioid-free anaesthesia should never represent the absence of analgesia. Rather, non-opioid analgesic interventions and medications should be routinely incorporated into every patient's peri-operative pain management plan as part of multi-modal analgesia (Fig. 1). Multi-modal analgesia is defined as using two or more modalities that act by different mechanisms to provide more effective pain control and decrease the reliance on opioids 9. Multi-modal analgesia has been recommended in the peri-operative and acute pain setting by major society guidelines 9, 10. Only seven of the studies included in the current meta-analysis explicitly mention the use of non-opioid analgesics. However, in this modern era of healthcare, we strongly discourage the use of opioid-only analgesia and stress the importance of offering multi-modal analgesia to all patients. Many non-opioid analgesic options are available. These include, but are not limited to, local anaesthetics, N-methyl-D-aspartate antagonists, paracetamol, non-steroidal anti-inflammatory drugs (NSAIDs), gabapentinoids and others (Fig. 1) 11. Second, the timeframe of interest for the study was limited to the intra-operative period. However, the clinically-relevant time interval has never been defined, and restricting the application of opioid-free anaesthesia to the intra-operative period potentially limits the impact of the intervention in terms of longer-term patient outcomes like chronic opioid use. In 15 out of the 23 studies included in the meta-analysis, all patients received postoperative parenteral opioids, and four studies did not specify the mode of postoperative analgesia, although we can assume opioids were involved 7. From a system point of view, we question the utility of avoiding opioids only within the operating theatre walls while allowing unrestricted opioid prescribing before the patient enters and after the patient leaves the operating theatre. In contrast, we have the potential to make the greatest impact if we apply opioid-free anaesthesia across the interval of ‘peri-operative time’ (Fig. 2). Opioid-free anaesthesia can be incorporated into an enhanced recovery protocol or clinical pathway that consistently applies multi-modal analgesia peri-operatively and even sets limits on discharge opioid prescribing 12, 13. Third, the use of remifentanil intra-operatively deserves special consideration. In the meta-analysis, 14 out of the 23 studies used remifentanil against control (placebo or no infusion) 7. This affects the generalisability of the study results. Does the control group experience less pain at 2 h due to avoidance of any opioid, or can these findings be specifically attributed to avoidance of remifentanil? Remifentanil is a potent short-acting intravenous opioid commonly used for infusion; it has rapid analgesic offset that can result in moderate-to-severe patient-reported pain after discontinuation 14. When administered at high doses, remifentanil has been implicated as a cause of opioid-induced hyperalgesia and acute opioid tolerance which both present clinically as increased opioid demand 14-16. Compared with acute tolerance which can be overcome by increasing the dose of opioid, opioid-induced hyperalgesia represents a form of sensitisation and cannot be overcome by increasing dosage 16. In addition, opioids and especially remifentanil are known causes of PONV. The present study provides no information on routine prophylaxis against PONV which has been recommended by guidelines produced in the USA and Europe 17, 18. It is not clear whether the increased incidence of PONV in the opioid-inclusive group can be wholly attributed to opioid administration vs. lack of prophylaxis. As we continue to adapt to increasing regulations regarding opioid prescribing, opioid-free anaesthesia has potential to offer anaesthetists an alternative to the current paradigm of opioid-inclusive balanced anaesthesia. With so many non-opioid analgesic options available, the task at hand will be creating guidelines and pathways to facilitate implementation and consistent use of these modalities. Changing clinical practice can be difficult at times 19, and the process of overcoming barriers to implementation must progress through changes in knowledge, attitudes and behaviour. Publishing studies like this latest meta-analysis by Frauenknecht et al. 7 and others on opioid-free anaesthesia help to disseminate knowledge. Adjusting attitudes can be more challenging, but a good starting point for anaesthetists may be to change the default question from ‘Why shouldn't I give an opioid?’ to ‘Why do I need to give an opioid?’ At this point, we still have plenty of research questions on the topic of opioid-free anaesthesia. As scientists, we have to design studies of opioid-free anaesthesia with rigorous methodology, an emphasis on outcomes that truly matter and equipoise. Opioid-free anaesthesia is of great interest within the anaesthetic community today due to the opioid epidemic, and hospital-wide initiatives have been launched all over the world to curb opioid prescribing 20. However, we have seen in recent years the pendulum swing from one extreme (using opioids to address ‘pain as the fifth vital sign’) 2 to the other (opioid-free anaesthesia). There will continue to be passionate debates about opioid prescribing and addiction, but we cannot lose sight of the goals of effective pain management and personalised patient care. For the sake of moving the conversation forward, we propose the following definition for opioid-free anaesthesia: ‘a peri-operative care strategy that maximises non-opioid modalities for anaesthesia and analgesia and reserves the use of opioids for severe acute pain unrelieved by other methods from admission to discharge from the hospital.’ Using Fig. 1 as a guide, a patient scheduled for total knee replacement without contra-indications can receive oral paracetamol and celecoxib pre-operatively; have a continuous nerve block performed by an anaesthetist skilled in regional anaesthesia; and undergo spinal anaesthesia for the surgery. If the patient receives general anaesthesia instead, intra-operative beta-blockade with esmolol as well as low-dose ketamine can be used to decrease administration of intra-operative and postoperative opioids 11, 21. Postoperatively, the pain management plan should start with non-pharmacologic interventions (e.g. cryotherapy) and regularly administered non-opioid analgesics (e.g. NSAIDs, paracetamol and perineural infusion of local anaesthetic, if applicable). Opioids can be prescribed on an as-needed basis for severe, unrelieved breakthrough pain. In-hospital opioid consumption should drive discharge prescribing; non-opioid analgesics should be continued at home and each patient's opioid prescription should be individualised by dose with explicit instructions for tapering, cessation and disposal. Perhaps the evidence one day will tell us that not all opioids are bad as long as they are used sparingly for appropriate indications within the context of multi-modal analgesia 22, and innovative technology may help prevent opioid diversion and overdose 23. If all anaesthetists implemented this strategy in the future, we will no longer need the term ‘opioid-free anaesthesia’ because we will all just agree to call it ‘anaesthesia’. No conflict of interest declared.
No takes yet. Share an insight, caveat, or question.
Elkassabany et al. (2019) conducted an editorial in Peri-operative pain. Opioid-free anaesthesia vs. Opioid-inclusive anaesthesia was evaluated on Postoperative rest pain at 2 h and postoperative nausea and vomiting (PONV). Opioid-free anaesthesia lacks a universal definition, and peri-operative care should instead focus on maximizing non-opioid multi-modal analgesia while reserving opioids for severe acute pain.
Synapse has enriched 10 related papers. Consider them for comparative context: